WM-NET coordinates a portfolio of multi-center clinical trials investigating next-generation therapies for Waldenstrom macroglobulinemia. Supported by IWMF and rooted in long-standing collaborative relationships, WM-NET unifies leading clinicians and researchers to address the most important unanswered questions in WM care.
Click the link below to read more about WM-NET clinical trials: